Obesity Paradox and Recurrent Coronary Heart Disease in a Population-Based Study: Tehran Lipid and Glucose Study

Authors Information
Article Notes and Dates
To Cite : Asgari S, Barzin M, Hosseinpanah F, Hadaegh F, Azizi F, et al. Obesity Paradox and Recurrent Coronary Heart Disease in a Population-Based Study: Tehran Lipid and Glucose Study, Int J Endocrinol Metab. 2016 ;14(2):e59244. doi: 10.5812/ijem.37018.
Copyright: Copyright © 2016, International Journal of Endocrinology and Metabolism. .
Abstract
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009; 9: 88[DOI][PubMed]
  • 2. Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol. 2014; 63(25 Pt B): 2985-3023[DOI][PubMed]
  • 3. Inoue-Choi M, Lazovich D, Prizment AE, Robien K. Adherence to the World Cancer Research Fund/American Institute for Cancer Research recommendations for cancer prevention is associated with better health-related quality of life among elderly female cancer survivors. J Clin Oncol. 2013; 31(14): 1758-66[DOI][PubMed]
  • 4. D'Agostino RB, Russell MW, Huse DM, Ellison RC, Silbershatz H, Wilson PW, et al. Primary and subsequent coronary risk appraisal: new results from the Framingham study. Am Heart J. 2000; 139(2 Pt 1): 272-81[PubMed]
  • 5. Hadaegh F, Harati H, Ghanbarian A, Azizi F. Prevalence of coronary heart disease among Tehran adults: Tehran Lipid and Glucose Study. East Mediterr Health J. 2009; 15(1): 157-66[PubMed]
  • 6. Khalili D, Sheikholeslami FH, Bakhtiyari M, Azizi F, Momenan AA, Hadaegh F. The incidence of coronary heart disease and the population attributable fraction of its risk factors in Tehran: a 10-year population-based cohort study. PLoS One. 2014; 9(8)[DOI][PubMed]
  • 7. Hadaegh F, Mohebi R, Cheraghi L, Tohidi M, Moghaddam NB, Bozorogmanesh M, et al. Do different metabolic syndrome definitions predict cerebrovascular events and coronary heart disease independent of their components?: 9 years follow-up of the tehran lipid and glucose study. Stroke. 2012; 43(6): 1669-71[DOI][PubMed]
  • 8. Uretsky S, Messerli FH, Bangalore S, Champion A, Cooper-Dehoff RM, Zhou Q, et al. Obesity paradox in patients with hypertension and coronary artery disease. Am J Med. 2007; 120(10): 863-70[DOI][PubMed]
  • 9. Younge JO, Damen NL, van Domburg RT, Pedersen SS. Obesity, health status, and 7-year mortality in percutaneous coronary intervention: in search of an explanation for the obesity paradox. Int J Cardiol. 2013; 167(4): 1154-8[DOI][PubMed]
  • 10. Bucholz EM, Rathore SS, Reid KJ, Jones PG, Chan PS, Rich MW, et al. Body mass index and mortality in acute myocardial infarction patients. Am J Med. 2012; 125(8): 796-803[DOI][PubMed]
  • 11. Fonarow GC, Srikanthan P, Costanzo MR, Cintron GB, Lopatin M, Adhere Scientific Advisory Committee , et al. An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J. 2007; 153(1): 74-81[DOI][PubMed]
  • 12. Herment A, Giovannelli JF. An adaptive approach to computing the spectrum and mean frequency of Doppler signals. Ultrason Imaging. 1995; 17(1): 1-26[PubMed]
  • 13. Romero-Corral A, Montori VM, Somers VK, Korinek J, Thomas RJ, Allison TG, et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet. 2006; 368(9536): 666-78[DOI][PubMed]
  • 14. Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials. 2009; 10: 5[DOI][PubMed]
  • 15. Khalili. D, KMosavi-Jarrahi A, Eskandari F, Mousavi-Jarrahi Y, Hadaegh F, Mohagheghi M, et al. Evaluation of cause of deaths’ validity using outcome measures from a prospective, population based cohort study in Tehran, Iran PLoS One 2012; 7(2)[DOI][PubMed]
  • 16. Wilson PW, D’Agostino RS, WBhatt DL, Eagle K, et al. An international model to predict recurrent cardiovascular disease Am J Med 2012; 125(7): 695-703[DOI][PubMed]
  • 17. Ainsworth BE, Jacobs DR, Leon AS. Validity and reliability of self-reported physical activity status: the Lipid Research Clinics questionnaire Medicine and science in sports and exercise 1993; 25(1): 92-98
  • 18. Sharma A, Vallakati A, Einstein AJ, Lavie CJ, et al. Relationship of body mass index with total mortality, cardiovascular mortality, and myocardial infarction after coronary revascularization: evidence from a meta-analysis. Mayo Clin Proc 2014; 89(8): 1080-100[DOI][PubMed]
  • 19. Niedziela J, Hudzik B, Niedziela N, Gasior M, et al. The obesity paradox in acute coronary syndrome: a meta-analysis. Eur J Epidemiol 2014; 29(11): 801-12[DOI][PubMed]
  • 20. Kalantar-Zadeh K, Rhee CM, Amin AN. To legitimize the contentious obesity paradox Mayo Clin Proc 2014; 89(8): 1033-5[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiaion Alert via Google Reader

Cited By:

International Journal of Endocrinology and Metabolism accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check